6-minute walk test
6-minute walk test is an intervention with 23 clinical trials. Currently 4 active trials ongoing. Historical success rate of 93.3%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
93.3%
14 of 15 finished
6.7%
1 ended early
4
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon
Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Individualized Physical Activity and Carotid Plaque Instability
6 Minute Walk Test in Cystic Fibrosis
Clinical Trials (23)
Follow-up Study in French Practice to Evaluate Improvements in Walking and Pain Relief in Patients Treated With Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon
Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Individualized Physical Activity and Carotid Plaque Instability
6 Minute Walk Test in Cystic Fibrosis
Kinematics of Obese Patients Perambulation
Characterization and Longitudinal Monitoring of Muscular Phenotype in Patients Admitted to Intensive Care for Sepsis
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)
Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiovascular or Respiratory Diseases
Correlation Between Physical Fitness Status and Quality of Postoperative Recovery in Gynaecological ERAS Patients
Assessment of Body Composition and Physical Function
BIO-2-HEART: Identification of Biomarkers in T2DM and Heart Failure
Evaluation of the Muscular FORCE in the Upper Limbs of Patients Presenting a Thoracic Outlet Syndrome
Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR
Determinants of Functional Capacity in Children With Asthma
Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease
The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus
Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases
Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test
Sit-to-stand Test in Cystic Fibrosis Children and Adolescents
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 23